Uptake of DPYD and UGT1A1 testing in Italy and adherence to pharmacogenetic guidelines: A 5-year perspective from an EQA provider.

Regarding the accuracy of clinical interpretation stratified by the guideline referenced, there is a clear trend showing a decrease in clinical interpretation errors over the years, particularly for reports referencing the SIF‐AIOM guidelines, with errors decreasing to only 13% in 2023 (Figure 3D ). 3.6.

also in 9,198 other papers

It highlights an encouraging trend toward improved accuracy and guideline adherence, reflecting increasing awareness and harmonization in clinical pharmacogenetic practice.

also in 160 other papers